Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Analyst picks & changes

Centocor Inc.

(CNTO)

Genentech Inc.

(GNE)

Vector Securities International analyst Peter Drake said the settlement of the human growth hormone dispute between GNE and

Eli Lilly and Co.

Read the full 294 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE